ArticleBMC medicine2011

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.

Mark Jit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.